Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RJL Systems is a private U.S. medical device company focused on bioelectrical impedance analysis (BIA) for body composition and fluid assessment. Founded in 1979, the company develops and sells FDA-approved Class II BIA analyzers, associated software, electrodes, and accessories used by clinicians, researchers, wellness professionals, hospitals, universities, and government customers. Its core commercial products include the Quantum analyzer family for whole-body and segmental assessment, measuring parameters such as fat mass, lean mass, total body water, hydration, and phase angle. RJL Systems positions itself as a long-established pioneer in BIA and emphasizes clinically validated, non-invasive, portable body composition analysis rather than therapeutics or drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RJL Systems.